COPPOLA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.362
EU - Europa 504
AS - Asia 260
AF - Africa 21
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.159
Nazione #
US - Stati Uniti d'America 1.298
IT - Italia 259
CN - Cina 209
NL - Olanda 71
CA - Canada 62
FI - Finlandia 34
SE - Svezia 33
VN - Vietnam 28
IE - Irlanda 26
UA - Ucraina 26
CI - Costa d'Avorio 21
DE - Germania 18
GB - Regno Unito 18
BR - Brasile 10
IN - India 10
FR - Francia 7
JP - Giappone 7
NO - Norvegia 4
PL - Polonia 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
MX - Messico 2
SG - Singapore 2
AR - Argentina 1
BE - Belgio 1
EU - Europa 1
MK - Macedonia 1
PK - Pakistan 1
SM - San Marino 1
TR - Turchia 1
Totale 2.159
Città #
Chandler 260
Boston 94
Millbury 93
Des Moines 79
Princeton 78
Ashburn 69
Nanjing 69
Amsterdam 68
Ottawa 58
Naples 51
Napoli 46
Lawrence 45
Beijing 40
Jacksonville 30
Dong Ket 28
Norwalk 26
Shenyang 24
Ann Arbor 21
Hebei 21
Wilmington 21
Nanchang 13
Milan 12
Woodbridge 12
Jiaxing 11
Castelnuovo Rangone 10
Houston 10
Fairfield 9
Lappeenranta 9
Boardman 8
Changsha 8
Kagoya 6
Redwood City 6
Tianjin 6
Borgosatollo 5
Bologna 4
Catania 4
Chengdu 4
Hangzhou 4
Kronberg 4
Minori 4
Oslo 4
West Jordan 4
Binasco 3
Cambridge 3
Caserta 3
Castellarano 3
Falls Church 3
Los Angeles 3
Nancy 3
Pune 3
Seattle 3
Washington 3
Afragola 2
Aversa 2
Bowling Green 2
Brno 2
Dublin 2
Florence 2
Formia 2
Fort Worth 2
Guadalajara 2
Guangzhou 2
Hong Kong 2
Kunming 2
Munich 2
New York 2
Redmond 2
Rome 2
Salerno 2
San Mateo 2
Siano 2
Siracusa 2
Verona 2
Wuhan 2
Acerra 1
Akron 1
Apo 1
Baton Rouge 1
Capodrise 1
Concordia 1
Fremont 1
Grammichele 1
Grosseto 1
Gurgaon 1
Lahore 1
Leuven 1
Limatola 1
London 1
Luzzano 1
Marano di Napoli 1
Melito di Napoli 1
Nashville 1
Orange 1
Pisa 1
Portici 1
Pozzo 1
Pozzuoli 1
San Benigno Canavese 1
Santa Maria La Carita 1
Scafati 1
Totale 1.478
Nome #
Bergmeister's papilla in a young patient with type 1 sialidosis: Case report 77
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). 64
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 45
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. 44
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 44
Diagnostic implications of genetic copy number variation in epilepsy plus 44
Familial mesial temporal lobe epilepsy (FMTLE) : a clinical and genetic study of 15 Italian families. 42
Diagnosis and management of type 1 sialidosis: Clinical insights from long-term care of four unrelated patients 38
KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. 38
Epileptic myoclonus as ciprofloxacin-associated adverse effect. 37
Inherited neuromyotonia: A clinical and genetic study of a family. 36
A de novo 11p12-p15.4 duplication in a patient with pharmacoresistant epilepsy, mental retardation, and dysmorphisms. 35
Alterations in the α2δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies 35
Epilepsy in Rett syndrome: can seizures play an encephalopathic effect in this disorder? 35
Abnormal sensorimotor cortex and thalamo-cortical networks in familial adult myoclonic epilepsy type 2: pathophysiology and diagnostic implications 34
From cannabis to cannabidiol to treat epilepsy, where are we? 33
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 33
The syndrome gelastic seizures-hypothalamic hamartoma: severe, potentially reversible encephalopathy. 31
Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2 31
GABAergic dysfunction mediates motor impairment in Rett syndrome 31
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome. 31
17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome 30
Chewing induced reflex seizures (“eating epilepsy”) and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases 30
Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case. 29
The spectrum of intermediate SCN8A-related epilepsy 29
The challenges of treating epilepsy with 25 antiepileptic drugs 28
Cortical tremor: a tantalizing conundrum between cortex and cerebellum 28
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 27
Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases. 27
CHD2 variants are a risk factor for photosensitivity in epilepsy 27
Milder presentation of TELO2-related syndrome in two sisters homozygous for the p.Arg609His pathogenic variant 27
A pilot open-label trial of zonisamide inUnverricht-Lundborg disease. 26
Different electroclinical picture of generalized epilepsy in two families with 15q13.3 microdeletion. 25
Difficult-to-treat absences in a female patient with ornithin-transcarbamylase (OTC) deficit 25
The occurrence of lateral shift in cervical dystonia 25
Characterization of a recurrent 15q24 microdeletion syndrome 24
Xq25 microduplication syndrome: A further contribution to its definition. A case report and review of the literature 24
Temporal lobe malformations, focal epilepsy, and FGFR3 mutations: a non-causal association? 24
Rare coding variants in genes encoding GABAAreceptors in genetic generalised epilepsies: an exome-based case-control study 23
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis 23
A clinical and genetic study of 33 new cases with early-onset absence epilepsy. 22
Antibiotics and de novo status epilepticus 22
Epilepsy and mental retardation in a patient with 15q 24.1-25.1 interstitial deletion revealed by array-CGH 22
Reflex seizures and reflex epilepsies: old models for understanding mechanisms of epileptogenesis. 21
Neurological features and long-term follow-up in 15q11.2-13.1 duplication. 21
Animal models 21
6q terminal deletion: An emerging syndrome associated to a peculiar clinical and electroencephalographic picture 21
Epilepsy, cerebral calcifications, and gluten-related disorders: Are anti-transglutaminase 6 antibodies the missing link? 21
Dual diagnosis in a child with familial SCN8A-related encephalopathy complicated by a 1p13.2 deletion involving NRAS gene 21
Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy 20
Antiepileptic drugs under investigation for treatment of focal epilepsy 20
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy 20
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study) 19
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 19
Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. 18
High-functioning autism spectrum disorder with fluent speech and late-onset epilepsy: an unusual presentation of Inv-Dup (15) syndrome. 18
Neurophysiological Signatures of Motor Impairment in Patients with Rett Syndrome 18
Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation 18
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences 18
Neuropsychological findings in patients with Unverricht-Lundborg disease. 17
Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies. 17
TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy 16
Targeted re-sequencing in malformations of cortical development: genotype-phenotype correlations 15
Serum MHD monitoring may be useful in the management of side effects in epileptic patients on high doses of oxcarbazepine. 14
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes 14
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies 14
Psychiatric comorbidities in patients from seven families with autosomal dominant cortical tremor, myoclonus, and epilepsy 13
Management of epilepsy in brain tumors 13
Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature 13
Epilepsy in KAT6A syndrome: Description of two individuals and revision of the literature 13
Novel biallelic variants expand the phenotype of NAA20-related syndrome 12
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 12
GLUT-1 deficiency syndrome: Atypical variants associated with new mutations in SLC2A1 gene 12
Photosensitive epilepsy is associated with reduced inhibition of alpha rhythm generating networks 12
Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. 11
Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. 11
Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization. 11
Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases 11
Myoclonic epilepsy in a child with 17q22-q23.1 deletion 11
De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides–Baraitser syndrome 11
Seizures in children with neurofibromatosis type 1: Is neurofibromatosis type 1 enough? 10
West syndrome associated with 14q12 duplications harboring FOXG1 10
Severe epilepsy in an adult with partial trisomy 18q 10
Erratum: Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy (Epilepsia (2013) 54 (256-264) DOI:10.1111/epi.12517) 10
Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients 10
copy number variations causing epilepsy 10
Epilepsy and Immune System: A Tour Around the Current Literature 10
Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. 9
Progress from genome-wide association studies and copy number variant studies in epilepsy 9
Modeling new therapies for infantile spasms 9
Efficacy and tolerability of Zonisamide (Zonegran™) in ULD: A pilot open-label trial 9
The syndrome gelastic seizures-hypothalamic hamartoma: Description of a case study 9
Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Does "SMEI plus" exist? 9
Pediatric diagnosis not made until adulthood: A case of Wolf-Hirschhorn syndrome 9
Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution 9
Why is the developing brain more susceptible to status epilepticus? 9
Effectiveness of antiepileptic therapy in patients with PCDH19 mutations 9
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor 9
Dissecting genetics of spectrum of epilepsies with eyelid myoclonia by exome sequencing 8
Copy number variants and epilepsy: New emerging syndromes 8
Totale 2.177
Categoria #
all - tutte 10.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 3 1
2019/2020299 148 22 9 4 6 4 1 0 2 22 71 10
2020/2021268 7 5 18 95 7 24 22 4 19 24 14 29
2021/2022584 85 5 3 3 8 8 9 20 44 30 73 296
2022/2023674 128 53 16 30 74 78 0 64 89 72 44 26
2023/2024342 22 88 49 28 33 40 17 35 5 21 4 0
Totale 2.375